Table 4.

The table shows the daily p-SAPS II evaluation compared to the admission PIM 3 of the patients still in the study at the given timepoint.

Day	N	AUROC p-SAPS II (95% CI, p)	AUROC PIM 3(95% CI, p)	Difference (p)	Goodness of fit p-SAPS II (p)	Observed/expected (Ratio)
2	235	0.88 (0.83–0.93, p < 0.001)	0.716 (0.515–0.0917, p = 0.012)	0.164 (0.095)	13.42 (0.004)	12/32.5 (0.369)
3	234	0.86 (0.78–0.94, p < 0.001	0.704 (0.49–0.92, p = 0.023)	0.156 (0.15)	32.92 (<0.001)	11/52.15 (0.211)
7	129	0.895 (0.82–0.97, p < 0.001)	0.729 (0.51–0.95, p = 0.114)	0.165 (0.168)	8.74 (0.068)	9/21.95 (0.41)
14	51	0.857 (0.75–0.97, p = 0.002)	0.698 (0.45–0.94, p = 0.125)	0.159 (0.168)	3.15 (0.53)	8/14.2 (0.563)
21	27	0.889 (0.76–1, p = 0.003)	0.714 (0.44–0.99, p = 0.102)	0.175 (0.288)	1.82 (0.612)	7/6.65 (1.05)
28	17	0.96 (0.86–1, p = 0.005)	0.64 (0.29–0.99, P = 0.391)	0.32 (0.131)	0.296 (0.961)	5/4.25 (1.18)

Throughout the clinical stay, the AUROC value increases although significant differences to PIM 3 were not detected. The goodness of fit test shows improvement of fitting over time. With O/E ratios adjusting to One.